1. Anderson D, Faber P, Marcovitz S, Hardy J, Lorenzetti D. Pituitary tumors and the ophthalmologist. Ophthalmology. 1983; 90:1265–1270. PMID:
6664664.
Article
2. Anderson DR. Perimetry: With and Without Automation. ed 2. St. Louis: Mosby;1987.
3. Chang EF, Zada G, Kim S, Lamborn KR, Quinones-Hinojosa A, Tyrrell JB, et al. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg. 2008; 108:736–745. PMID:
18377253.
Article
4. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery. 1997; 40:225–236. discussion 236-237. PMID:
9007854.
Article
5. Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery. 1985; 17:446–452. PMID:
4047355.
Article
6. Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer. 2008; 15:905–915. PMID:
18780796.
Article
7. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 1986; 64:713–719. PMID:
3701419.
Article
8. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004; 101:613–619. PMID:
15274075.
9. Fahlbusch R, Schott W. Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes. J Neurosurg. 2002; 96:235–243. PMID:
11838796.
Article
10. Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M, Reimondo G, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006; 155:823–829. PMID:
17132751.
Article
11. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005; 47:458–472. PMID:
16161804.
Article
12. Foroozan R. Chiasmal syndromes. Curr Opin Ophthalmol. 2003; 14:325–331. PMID:
14615635.
Article
13. Garibi J, Pomposo I, Villar G, Gaztambide S. Giant pituitary adenomas: clinical characteristics and surgical results. Br J Neurosurg. 2002; 16:133–139. PMID:
12046731.
Article
14. Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry. 2005; 76:415–419. PMID:
15716538.
Article
15. Goel A, Nadkarni T, Muzumdar D, Desai K, Phalke U, Sharma P. Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol. 2004; 61:436–445. discussion 445-446. PMID:
15120215.
Article
16. Hennessey JV, Jackson IM. Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly. Baillieres Clin Endocrinol Metab. 1995; 9:271–314. PMID:
7625986.
Article
17. Hollenhorst RW, Younge BR. Ocular manifestations produced by adenomas of the pituitary gland: analysis of 1000 cases. In : Kohler PO, Ross GT, editors. Diagnosis and Treatment of Pituitary Tumors. Amsterdam: Excepta Medica;1973. p. 53–63.
18. Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma. Acta Neurol Scand. 1995; 92:157–160. PMID:
7484065.
Article
19. Jaeger W, Thomann H. [German Ophthalmological Association. Recommendations for evaluation of reduced earning capacity caused by damage to vision. September 1981]. Klin Monbl Augenheilkd. 1982; 180:242–244. PMID:
7078020.
20. Jaffe CA. Clinically non-functioning pituitary adenoma. Pituitary. 2006; 9:317–321. PMID:
17082898.
Article
21. Kerrison JB, Lynn MJ, Baer CA, Newman SA, Biousse V, Newman NJ. Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol. 2000; 130:813–820. PMID:
11124302.
Article
22. Krisht AF. Giant invasive pituitary adenomas: management plan. Contemp Neurosurg. 1999; 21:1–5.
23. Lee JP, Park IW, Chung YS. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma. Korean J Ophthalmol. 2011; 25:37–41. PMID:
21350693.
Article
24. Levy A. Pituitary disease: presentation, diagnosis, and management. J Neurol Neurosurg Psychiatry. 2004; 75(Suppl 3):iii47–iii52. PMID:
15316045.
Article
25. Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. ed 4. Baltimore: Williams & Wilkins;1988. p. 1433–1484.
26. Miller NR, Newman NJ, Biousse V, Kerrison JB. Walsh & Hoyt's Clinical Neuro-Ophthalmology. ed 6. Philadelphia: Lippincott Williams & Wilkins;2005. p. 503–573.
27. Monteiro ML, Zambon BK, Cunha LP. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression. Can J Ophthalmol. 2010; 45:404–408. PMID:
20648089.
Article
28. Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M. Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery. 2007; 60:993–1002. discussion 1003-1004. PMID:
17538372.
29. Müslüman AM, Cansever T, Yılmaz A, Kanat A, Oba E, ÇavuŞoğlu H, et al. Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes. World Neurosurg. 2011; 76:141–148. discussion 63-66. PMID:
21839965.
Article
30. Nishimura M, Kurimoto T, Yamagata Y, Ikemoto H, Arita N, Mimura O. Giant pituitary adenoma manifesting as homonymous hemianopia. Jpn J Ophthalmol. 2007; 51:151–153. PMID:
17401630.
Article
31. Peter M, De Tribolet N. Visual outcome after transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995; 9:151–157. PMID:
7632360.
Article
32. Powell M. Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995; 9:367–373. PMID:
7546358.
Article
33. Rivoal O, Brézin AP, Feldman-Billard S, Luton JP. Goldmann perimetry in acromegaly: a survey of 307 cases from 1951 through 1996. Ophthalmology. 2000; 107:991–997. PMID:
10811095.
34. Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary. 2012; 15:71–83. PMID:
21918830.
Article
35. Sivakumar W, Chamoun R, Nguyen V, Couldwell WT. Incidental pituitary adenomas. Neurosurg Focus. 2011; 31:E18. PMID:
22133173.
Article
36. Thomas R, Shenoy K, Seshadri MS, Muliyil J, Rao A, Paul P. Visual field defects in non-functioning pituitary adenomas. Indian J Ophthalmol. 2002; 50:127–130. PMID:
12194569.
37. Westheimer G. Visual acuity. In : Kaufman PL, Alm A, Adler FH, editors. Adler's Physiology of the Eye : clinical application. ed 10. St. Louis, MO: CV Mosby;2003. p. 453–469.
38. Wilson CB. Surgical management of pituitary tumors. J Clin Endocrinol Metab. 1997; 82:2381–2385. PMID:
9253304.
Article
39. Zhang X, Fei Z, Zhang J, Fu L, Zhang Z, Liu W, et al. Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol. 1999; 52:380–385. PMID:
10555844.
Article
40. Zhang X, Fei Z, Zhang W, Zhang JN, Liu WP, Fu LA, et al. Endoscopic endonasal transsphenoidal surgery for invasive pituitary adenoma. J Clin Neurosci. 2008; 15:241–245. PMID:
18207408.
Article